Charlotte Hulme c.hulme1@keele.ac.uk
A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications
Hulme, Charlotte H.; Mennan, Claire; McCarthy, Helen S.; Davies, Rebecca; Lan, Tian; Rix, Larissa; Perry, Jade; Wright, Karina
Authors
Claire Mennan
Helen McCarthy h.s.mccarthy@keele.ac.uk
Rebecca Davies
Tian Lan
Larissa Rix
Jade Perry j.k.l.perry1@keele.ac.uk
Karina Wright k.t.wright@keele.ac.uk
Abstract
The Quantum cell expansion system manufactured by Terumo-BCT is perhaps the most widely reported Good Manufacturing Practice–compliant bioreactor used for the expansion of adherent cell populations, both for research purposes and clinical cell–based therapies/trials. Although the system was originally designed for adherent cell expansion, more recently suspension cultures and extracellular vesicle manufacturing protocols have been published using the Quantum system. Cell therapy research and regenerative medicine in general is a rapidly expanding field and as such it is likely that the use of this system will become even more widespread and perhaps mandatory, for both research and development and in the clinic. The purpose of this review is to describe, compare and discuss the diverse range of research and clinical applications currently using the Quantum system, which to our knowledge has not previously been reviewed. In addition, current and future challenges will also be discussed.
Citation
Hulme, C. H., Mennan, C., McCarthy, H. S., Davies, R., Lan, T., Rix, L., …Wright, K. (2023). A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications. Cytotherapy, 25(10), 1017-1026. https://doi.org/10.1016/j.jcyt.2023.04.004
Journal Article Type | Review |
---|---|
Acceptance Date | Apr 10, 2023 |
Online Publication Date | Sep 22, 2023 |
Publication Date | 2023-10 |
Publicly Available Date | May 30, 2023 |
Journal | Cytotherapy |
Print ISSN | 1465-3249 |
Publisher | Elsevier |
Volume | 25 |
Issue | 10 |
Pages | 1017-1026 |
DOI | https://doi.org/10.1016/j.jcyt.2023.04.004 |
Keywords | bioreactor; cell therapy; extracellular vesicles; Good Manufacturing Practice; Quantum; up-scale manufacture |
Public URL | https://keele-repository.worktribe.com/output/427211 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S146532492300097X?via%3Dihub |
Files
1-s2.0-S146532492300097X-main.pdf
(791 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
437 CHARACTERISATION OF JUVENILE CARTILAGE TISSUES AND THEIR ISOLATED CHONDROCYTES FOR ALLOGENEIC CHONDROCYTE THERAPY
(2024)
Presentation / Conference
681 USING NANOPORE SEQUENCING TO DIAGNOSE PROSTHETIC JOINT INFECTIONS
(2024)
Presentation / Conference
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search